Results 21 to 30 of about 36,882 (280)
Frontiers in Oncology, 2022 Gastric cancer (GC) ranks as the most common gastrointestinal cancer and is among the leading causes of cancer death worldwide. Glaucocalyxin A (GLA), an entkauranoid diterpene isolated from Rab-dosia japonica var., possesses various bioactivities.
Yanqi Liu +3 more
doaj +1 more source
Mìžnarodnij Endokrinologìčnij Žurnal, 2015 This review, consisting of two parts, considers a new formulation of insulin glargine (rDNA origin) in the form of injections 300 U/ml (Gla-300, Toujeo®).
V.V. Poltorak +2 more
doaj +1 more source
Drug Delivery, 2019 Glaucocalyxin A (GLA), is a diterpenoid extracted from Hara and has been studied for decades for its diverse bioactivities. However, GLA presents poor solubility in water and low bioavailability through oral administration which has hindered its ...
Lili Ren, Jingjing Wang, Guoguang Chen
doaj +1 more source
Mìžnarodnij Endokrinologìčnij Žurnal, 2015 This review, consisting of two parts, considers a new formulation of insulin glargine (rDNA origin) in the form of injections 300 U/ml (Gla-300, Toujeo®).
V.V. Poltorak +2 more
doaj +1 more source
Frontiers in Microbiology, 2022 Mucor circinelloides WJ11, an oleaginous filamentous fungus, produces 36% lipid of its cell dry weight when cultured in a high C/N ratio medium, however, the yield of γ-linolenic acid (GLA) is insufficient to make it competitive with other plant sources.
Xiuwen Wang +11 more
doaj +1 more source
Regeneration in Zebrafish (Danio rerio) fins: pattern of expression of mineralization–related Gla proteins [PDF]
, 2006 Teleost fishes have the exceptional ability to largely regenerate severed appendages comprising several different tissues. Fin regeneration starts through the formation of heterogeneous mesenchyma-like cells, named blastema, and located between stump ...
Brito, A. B. +2 more
core +1 more source
Mìžnarodnij Endokrinologìčnij Žurnal, 2016 This review examines the new formulation of insulin glargine (recombinant) in the form of injections 300 U/ml (Gla‑300, Toujeo®). Gla‑300 is a next generation basal insulin with a novel formulation of insulin glargin delivering the same amount of insulin,
V.V. Poltorak
doaj +1 more source
International Journal of Pharmaceutics: XGlabridin (Gla) has been reported to have significant effects in scar treatment, and however, the water insolubility of Gla leads to its poor transdermal absorption ability, which affects its bioactivities.
Juan Guo +10 more
doaj +1 more source
Orphanet Journal of Rare Diseases, 2022 Background Fabry disease (FD, OMIM #301500) is an X-linked lysosomal disorder caused by the deficiency of α-galactosidase A (α-GalA), encoded by the GLA gene.
Xuantong Dai +5 more
doaj +1 more source